Sofgen Pharma S.A. ( PROCF) - Key Metrics
PROCF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2023Q4 | $0.99 | -$0.01 | $0.24 | $0.16 |
| 2023Q3 | $1.17 | $0.08 | $0.37 | $0.33 |
| 2023Q2 | $1.09 | $0.27 | $0.12 | $0.08 |
| 2023Q1 | $0.83 | $0.07 | -$0.04 | -$0.07 |
| 2022Q4 | $0.90 | $0.09 | -$0.07 | -$0.14 |
PROCF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2023Q4 | 0% | -80.12 |
| 2023Q3 | 0% | 11.16 |
| 2023Q2 | 0% | 3.98 |
| 2023Q1 | 0% | 17.21 |
| 2022Q4 | 0% | 14.19 |
PROCF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2023Q4 | 3.84% | 0% |
| 2023Q3 | 9.20% | 0% |
| 2023Q2 | 1.92% | 0% |
| 2023Q1 | -1.55% | 0% |
| 2022Q4 | -2.64% | 0% |
PROCF
Price: $0.02
52 week price:
Earnings Per Share: 0.40 USD
P/E Ratio: 0.06
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 232724